ArticleInternational journal of molecular sciences2023

PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.

Tung-Tai Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.